Modeling complex metabolic reactions, ecological systems, and financial and legal networks with MIANN models based on Markov-Wiener node descriptors

Journal of Chemical Information and Modeling

Volumn 54, Issue 1, 2014, Pages 16-29

  Duardo Sánchez, Aliuska ^a,b   Munteanu, Cristian R ^a   Riera Fernández, Pablo ^a   López Díaz, Antonio ^b   Pazos, Alejandro ^a   González Díaz, Humberto ^c,d  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; ECOLOGY; GRAPH THEORY; MARKOV CHAINS; METABOLISM; MOLECULAR STRUCTURE; NEURAL NETWORKS; SOCIAL NETWORKING (ONLINE); STOCHASTIC SYSTEMS;

BIOLOGICAL NETWORKS; COMPUTATIONAL ALGORITHM; ECOLOGICAL SYSTEMS; EXPLORATORY STUDIES; METABOLIC REACTIONS; NON-LIVING SYSTEMS; NUMERICAL PARAMETERS; PROTEIN INTERACTION;

COMPLEX NETWORKS;

ALGORITHM; ARTIFICIAL NEURAL NETWORK; BIOLOGICAL MODEL; BIOLOGY; COMPUTER PROGRAM; ECOSYSTEM; FACTUAL DATABASE; JURISPRUDENCE; METABOLISM; PROBABILITY; SOCIAL SUPPORT; STATISTICAL MODEL; THEORETICAL MODEL;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; ECOSYSTEM; JURISPRUDENCE; MARKOV CHAINS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; MODELS, ECONOMETRIC; MODELS, THEORETICAL; NEURAL NETWORKS (COMPUTER); SOCIAL SUPPORT; SOFTWARE;

EID: 84893416568     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci400280n     Document Type: Article

References (146)

1. Todeschini, R. and Consonni, V. Handbook of Molecular Descriptors; Wiley-VCH: 2002.
2. Wiener, H. Structural determination of paraffin boiling points J. Am. Chem. Soc. 1947, 69, 17-20
3. Wiener, H. Correlation of heats of isomerization, and differences in heats of vaporization of isomers, among the paraffin hydrocarbons J. Am. Chem. Soc. 1947, 69, 2636-2638
4. Wiener, H. Relation of the physical properties of the isomeric alkanes to molecular structure. Surface tension, specific dispersion, and critical solution temperature in aniline J. Phys. Colloid Chem. 1948, 52, 1082-1089
5. Wiener, H. Vapor pressure-temperature relationships among the branched paraffin hydrocarbons J. Phys. Colloid Chem. 1948, 52, 425-430
6. Hosoya, H. Topological index, a newly proposed quantity characterizing the topological nature of structural isomers of saturated hydrocarbons Bull. Chem. Soc. Jpn. 1971, 44, 2332-2339
7. Hosoya, H. Mathematical meaning and importance of the topological index Z Croat. Chem. Acta 2007, 80, 239-249
8. Consonni, V.; Todeschini, R. Molecular descriptors. In Recent advances in QSAR studies: Methods and applications; Puzyn, T.; Leszczynski, J.; Cronin, M. T. D., Eds.; Springer: 2010; Chapter 3, pp 29-102.
9. Harary, F. Status and contrastatus Sociometry 1959, 22, 23-43
10. Diudea, M. V.; Gutman, I. Wiener-type topological indices Croat. Chem. Acta 1998, 71, 21-51
11. Todeschini, R.; Consonni, V. Molecular Descriptors for Chemoinformatics; Wiley-VCH: Weinheim, 2009; p 1257.
12. Balaban, A. T. From chemical graphs to 3D molecular modeling. In From chemical topology to three-dimensional geometry; Balaban, A. T., Ed.; Plenum Publishers: New York, 1997, p 420.
13. Mandloi, M.; Sikarwar, A.; Sapre, N. S.; Karmarkar, S.; Khadikar, P. V. A comparative QSAR study using Wiener, Szeged, and molecular connectivity indices J. Chem. Inf. Comput. Sci. 2000, 40, 57-62
14. Lukovits, I. Decomposition of the Wiener topological index. Application to drug-receptor interactions J. Chem. Soc., Perkin Trans. 2 1988, 1667-1671
15. Lukovits, I. Correlation between components of the Wiener index and partition coefficients of hydrocarbons Int. J. Quantum Chem. 1992, 44, 217-223
16. Mendiratta, S.; Madan, A. K. Structure-activity study on antiviral 5-vinylpyrimidine nucleoside analogs using Wiener's topological index J. Chem. Inf. Comput. Sci. 1994, 34, 867-871
17. Agrawal, V. K.; Srivastava, R.; Khadikar, P. V. QSAR studies on some antimalarial sulfonamides Bioorg. Med. Chem. 2001, 9, 3287-3293
18. Sardana, S.; Madan, A. K. Application of graph theory: Relationship of molecular connectivity index, Wiener's index and eccentric connectivity index with diuretic activity MATCH 2001, 43, 85-98
19. Sardana, S.; Madan, A. K. Predicting anticonvulsant activity of benzamides/benzylamines: computational approach using topological descriptors J. Comput.-Aided Mol. Des. 2002, 16, 545-550
20. Gupta, S.; Singh, M.; Madan, A. K. Application of graph theory: Relationship of eccentric connectivity Index and Wiener's Index with anti-inflammatory activity J. Math. Anal. Appl. 2002, 266, 259-268
21. Bajaj, S.; Sambi, S. S.; Madan, A. K. Predicting anti-HIV activity of phenethylthiazolethiourea (PETT) analogs: computational approach using Wiener's topochemical index J. Mol. Struct. 2004, 684, 197-203
22. Bajaj, S.; Sambi, S. S.; Madan, A. K. Topological models for prediction of anti-HIV activity of acylthiocarbamates Bioorg. Med. Chem. 2005, 13, 3263-3268
23. Bajaj, S.; Sambi, S. S.; Madan, A. K. Topological models for prediction of anti-inflammatory activity of N-arylanthranilic acids Bioorg. Med. Chem. Lett. 2004, 12, 3695-3701
24. Bajaj, S.; Sambi, S. S.; Madan, A. K. Topochemical models for prediction of anti-tumor activity of 3-aminopyrazoles Chem. Pharm. Bull. (Tokyo) 2005, 53, 611-615
25. Kumar, V.; Madan, A. K. Application of graph theory: prediction of glycogen synthase kinase-3 beta inhibitory activity of thiadiazolidinones as potential drugs for the treatment of Alzheimer's disease Eur. J. Pharm. Sci. 2005, 24, 213-218
26. Lather, V.; Madan, A. K. Topological model for the prediction of MRP1 inhibitory activity of pyrrolopyrimidines and templates derived from pyrrolopyrimidine Bioorg. Med. Chem. Lett. 2005, 15, 4967-4972
27. Bornholdt, S.; Schuster, H. G. Handbook of Graphs and Complex Networks: From the Genome to the Internet; WILEY-VCH: Wheinheim, 2003.
28. Boccaletti, S.; Latora, V.; Moreno, Y.; Chavez, M.; Hwang, D. U. Complex networks: Structure and dynamics Phys. Rep. 2006, 424, 175-308
29. Dehmer, M.; Emmert-Streib, F. Analysis of complex networks: from biology to linguistics; Wiley-Blackwell: Weinheim, 2009; p 462.
30. Newman, M. The structure and function of complex networks SIAM Rev. 2003, 45, 167-256
31. Thomas, S.; Bonchev, D. A survey of current software for network analysis in molecular biology Hum. Genomics 2010, 4, 353-360
32. Bonchev, D.; Buck, G. A. From molecular to biological structure and back J. Chem Inf. Model. 2007, 47, 909-917
33. Bonchev, D.; Rouvray, D. H. Complexity in Chemistry, Biology, and Ecology; Springer Science+Business Media, Inc.: New York, 2005.
34. Bonchev, D. Complexity analysis of yeast proteome network Chem. Biodivers. 2004, 1, 312-326
35. Bonchev, D. On the complexity of directed biological networks SAR QSAR Environ. Res. 2003, 14, 199-214
36. Gonzalez-Diaz, H. QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology, cancer, and neurosciences Curr. Pharm. Des. 2010, 16, 2598-2600
37. Gonzalez-Diaz, H. Network topological indices, drug metabolism, and distribution Curr. Drug. Metab 2010, 11, 283-284
38. Vina, D.; Uriarte, E.; Orallo, F.; Gonzalez-Diaz, H. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors Mol. Pharmaceutics 2009, 6, 825-835
39. Duardo-Sanchez, A.; Patlewicz, G.; González-Díaz, H. A review of network topological indices from chem-bioinformatics to legal sciences and back Curr. Bioinf. 2011, 6, 53-70
40. Puzyn, T.; Leszczynski, J.; Cronin, M. T. D. Recent Advances in QSAR Studies: Methods and applications; Springer: London, 2010; p 423.
41. González-Díaz, H.; Munteanu, C. R. Topological Indices for Medicinal Chemistry, Biology, Parasitology, Neurological and Social Networks; Transworld Research Network: Kerala, India, 2010.
42. González-Díaz, H.; González-Díaz, Y.; Santana, L.; Ubeira, F. M.; Uriarte, E. Proteomics, networks and connectivity indices Proteomics 2008, 8, 750-778
43. Gonzalez-Diaz, H.; Duardo-Sanchez, A.; Ubeira, F. M.; Prado-Prado, F.; Perez-Montoto, L. G.; Concu, R.; Podda, G.; Shen, B. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers Curr. Drug. Metab. 2010, 11, 379-406
44. Gonzalez-Diaz, H.; Prado-Prado, F.; Garcia-Mera, X.; Alonso, N.; Abeijon, P.; Caamano, O.; Yanez, M.; Munteanu, C. R.; Pazos, A.; Dea-Ayuela, M. A.; Gomez-Munoz, M. T.; Garijo, M. M.; Sansano, J.; Ubeira, F. M. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae J. Proteome Res. 2011, 10, 1698-1718
45. Rodriguez-Soca, Y.; Munteanu, C. R.; Dorado, J.; Pazos, A.; Prado-Prado, F. J.; Gonzalez-Diaz, H. Trypano-PPI: a web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein-protein interactions J. Proteome Res. 2010, 9, 1182-1190
46. Gonzalez-Diaz, H.; Romaris, F.; Duardo-Sanchez, A.; Perez-Montoto, L. G.; Prado-Prado, F.; Patlewicz, G.; Ubeira, F. M. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues Curr. Pharm. Des. 2010, 16, 2737-2764
47. Gonzalez-Diaz, H.; Prado-Prado, F. J.; Garcia-Mera, X.; Alonso, N.; Abeijon, P.; Caamano, O.; Yanez, M.; Munteanu, C. R.; Pazos Sierra, A.; Dea-Ayuela, M. A.; Gomez-Munoz, M. T.; Garijo, M. M.; Sansano, J.; Ubeira, F. M. MIND-BEST: web server for drugs & target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretic-experimental study of G3PD protein from Trichomona gallineae J. Proteome Res. 2010, 10, 1698-1718
48. Munteanu, C. R.; Vazquez, J. M.; Dorado, J.; Sierra, A. P.; Sanchez-Gonzalez, A.; Prado-Prado, F. J.; Gonzalez-Diaz, H. Complex network spectral moments for ATCUN motif DNA cleavage: first predictive study on proteins of human pathogen parasites J. Proteome Res. 2009, 8, 5219-5228
49. Concu, R.; Dea-Ayuela, M. A.; Perez-Montoto, L. G.; Bolas-Fernandez, F.; Prado-Prado, F. J.; Podda, G.; Uriarte, E.; Ubeira, F. M.; Gonzalez-Diaz, H. Prediction of enzyme classes from 3D structure: a general model and examples of experimental-theoretic scoring of peptide mass fingerprints of Leishmania proteins J. Proteome Res. 2009, 8, 4372-4382
50. Aguero-Chapin, G.; Varona-Santos, J.; de la Riva, G. A.; Antunes, A.; Gonzalez-Villa, T.; Uriarte, E.; Gonzalez-Diaz, H. Alignment-free prediction of polygalacturonases with pseudofolding topological indices: experimental isolation from coffea arabica and prediction of a new sequence J. Proteome Res. 2009, 8, 2122-2128
51. Santana, L.; Gonzalez-Diaz, H.; Quezada, E.; Uriarte, E.; Yanez, M.; Vina, D.; Orallo, F. Quantitative structure-activity relationship and complex network approach to monoamine oxidase a and B inhibitors J. Med. Chem. 2008, 51, 6740-6751
52. Gonzalez-Diaz, H.; Prado-Prado, F.; Ubeira, F. M. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach Curr. Top. Med. Chem. 2008, 8, 1676-1690
53. Aguero-Chapin, G.; Gonzalez-Diaz, H.; de la Riva, G.; Rodriguez, E.; Sanchez-Rodriguez, A.; Podda, G.; Vazquez-Padron, R. I. MMM-QSAR recognition of ribonucleases without alignment: comparison with an HMM model and isolation from Schizosaccharomyces pombe, prediction, and experimental assay of a new sequence J. Chem. Inf. Model. 2008, 48, 434-448
54. Aguero-Chapin, G.; Antunes, A.; Ubeira, F. M.; Chou, K. C.; Gonzalez-Diaz, H. Comparative study of topological indices of macro/supramolecular RNA complex networks J. Chem. Inf. Model. 2008, 48, 2265-2277
55. González-Díaz, H.; Vilar, S.; Santana, L.; Uriarte, E. Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices Curr. Top. Med. Chem. 2007, 7, 1025-1039
56. Ramos de Armas, R.; González-Díaz, H.; Molina, R.; Uriarte, E. Markovian backbone negentropies: molecular descriptors for protein research. I. Predicting protein stability in Arc repressor mutants Proteins 2004, 56, 715-723
57. González-Díaz, H.; Marrero, Y.; Hernandez, I.; Bastida, I.; Tenorio, E.; Nasco, O.; Uriarte, E.; Castanedo, N.; Cabrera, M. A.; Aguila, E.; Marrero, O.; Morales, A.; Perez, M. 3D-MEDNEs: an alternative ″in silico″ technique for chemical research in toxicology. 1. prediction of chemically induced agranulocytosis Chem. Res. Toxicol. 2003, 16, 1318-1327
58. Berca, M. N.; Duardo-Sanchez, A.; González-Díaz, H.; Pazos, A.; Munteanu, C. R. Markov entropy for biology, parasitology, linguistic, technology, social and law networks. In Complex Network Entropy: From Molecules to Biology, Parasitology, Technology, Social, Legal, and Neurosciences; González-Díaz, H.; Prado-Prado, F. J.; García-Mera, X., Eds.; Transworld Research Network: Kerala, India, 2011; Chapter 10, pp 127-142.
59. Aguiar-Pulido, V.; Seoane-Fernańdez, J. A.; Freire-Veiga, A. M.; Gonzalez-Diaz, H.; Duardo-Sanchez, A.; Dorado, J.; Pazos, A.; Munteanu, C. R. New Markov-Randic Centralities for Computational methods of Biology, Parasitology, Technology, Social and Law networks. Proceedings of ICCMSE 2010, Kos, Greece. AIP Conference Proceedings, Melville, NY, USA, accepted (2014).
60. González-Díaz, H.; Riera-Fernández, P.; Pazos, A.; Munteanu, C. R. The Rücker-Markov invariants of complex bio-systems: applications in parasitology and neuroinformatics Biosystems 2013, 111, 199-207
61. Riera-Fernandez, P.; Munteanu, C. R.; Dorado, J.; Martin-Romalde, R.; Duardo-Sanchez, A.; Gonzalez-Diaz, H. From chemical graphs in computer-aided drug design to general Markov-Galvez indices of drug-target, proteome, drug-parasitic disease, technological, and social-legal networks Curr. Comput.-Aided Drug Des. 2011, 7, 315-337
62. Gonzalez-Diaz, H.; Riera-Fernandez, P. New Markov-autocorrelation indices for re-evaluation of links in chemical and biological complex networks used in metabolomics, parasitology, neurosciences, and epidemiology J. Chem. Inf. Model. 2012, 52, 3331-3340
63. Riera-Fernández, P.; Munteanu, C. R.; Pedreira-Souto, N.; Martín-Romalde, R.; Duardo-Sanchez, A.; González-Díaz, H. Definition of Markov-Harary invariants and review of classic topological indices and databases in biology, parasitology, technology, and social-legal networks Curr. Bioinf. 2011, 6, 94-121
64. Estrada, E.; Delgado, E. J.; Alderete, J. B.; Jaña, G. A. Quantum-connectivity descriptors in modeling solubility of environmentally important organic compounds J. Comput. Chem. 2004, 25, 1787-1796
65. Besalu, E.; Girones, X.; Amat, L.; Carbo-Dorca, R. Molecular quantum similarity and the fundamentals of QSAR Acc. Chem. Res. 2002, 35, 289-295
66. Rincon, D. A.; Cordeiro, M. N.; Mosquera, R. A. On the electronic structure of cocaine and its metabolites J. Phys. Chem. A 2009, 113, 13937-13942
67. Mandado, M.; Gonzalez-Moa, M. J.; Mosquera, R. A. Chemical graph theory and n-center electron delocalization indices: a study on polycyclic aromatic hydrocarbons J. Comput. Chem. 2007, 28, 1625-1633
68. Gonzalez-Diaz, H.; Gonzalez-Diaz, Y.; Santana, L.; Ubeira, F. M.; Uriarte, E. Proteomics, networks and connectivity indices Proteomics 2008, 8, 750-778
69. Helguera, A. M.; Combes, R. D.; Gonzalez, M. P.; Cordeiro, M. N. Applications of 2D descriptors in drug design: a DRAGON tale Curr. Top. Med. Chem. 2008, 8, 1628-1655
70. Casanola-Martin, G. M.; Marrero-Ponce, Y.; Khan, M. T.; Ather, A.; Khan, K. M.; Torrens, F.; Rotondo, R. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays Eur. J. Med. Chem. 2007, 42, 1370-1381
71. Tetko, I. V.; Gasteiger, J.; Todeschini, R.; Mauri, A.; Livingstone, D.; Ertl, P.; Palyulin, V. A.; Radchenko, E. V.; Zefirov, N. S.; Makarenko, A. S.; Tanchuk, V. Y.; Prokopenko, V. V. Virtual computational chemistry laboratory - design and description J. Comput.-Aided Mol. Des. 2005, 19, 453-463
72. Marzaro, G.; Chilin, A.; Guiotto, A.; Uriarte, E.; Brun, P.; Castagliuolo, I.; Tonus, F.; Gonzalez-Diaz, H. Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors Eur. J. Med. Chem. 2011, 46, 2185-2192
73. Vilar, S.; Estrada, E.; Uriarte, E.; Santana, L.; Gutierrez, Y. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives J. Chem. Inf. Model. 2005, 45, 502-514
74. Estrada, E.; Quincoces, J. A.; Patlewicz, G. Creating molecular diversity from antioxidants in Brazilian propolis. Combination of TOPS-MODE QSAR and virtual structure generation Mol. Divers. 2004, 8, 21-33
75. Estrada, E.; Gonzalez, H. What are the limits of applicability for graph theoretic descriptors in QSPR/QSAR? Modeling dipole moments of aromatic compounds with TOPS-MODE descriptors J. Chem. Inf. Comput. Sci. 2003, 43, 75-84
76. Marrero-Ponce, Y.; Castillo-Garit, J. A.; Olazabal, E.; Serrano, H. S.; Morales, A.; Castañedo, N.; Ibarra-Velarde, F.; Huesca-Guillen, A.; Jorge, E.; del Valle, A.; Torrens, F.; Castro, E. A. TOMOCOMD-CARDD, a novel approach for computer-aided 'rational' drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds J. Comput.-Aided Mol. Des. 2004, 18, 615-634
77. Marrero-Ponce, Y.; Medina-Marrero, R.; Castro, A. E.; Ramos de Armas, R.; González-Díaz, H.; Romero-Zaldivar, V.; Torrens, F. Protein quadratic indices of the "macromolecular pseudograph's α-carbon atom adjacency matrix". 1. Prediction of Arc repressor alanine-mutant's stability Molecules 2004, 9, 1124-1147
78. Katritzky, A. R.; Oliferenko, A.; Lomaka, A.; Karelson, M. Six-membered cyclic ureas as HIV-1 protease inhibitors: a QSAR study based on CODESSA PRO approach. Quantitative structure-activity relationships Bioorg. Med. Chem. Lett. 2002, 12, 3453-3457
79. Katritzky, A. R.; Perumal, S.; Petrukhin, R.; Kleinpeter, E. Codessa-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities J. Chem. Inf. Comput. Sci. 2001, 41, 569-574
80. Vilar, S.; Cozza, G.; Moro, S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery Curr. Top. Med. Chem. 2008, 8, 1555-1572
81. Junker, B. H.; Koschutzki, D.; Schreiber, F. Exploration of biological network centralities with CentiBiN BMC Bioinf. 2006, 7, 219
82. Batagelj, V.; Mrvar, A. Pajek-analysis and visualization of large networks Lect. Notes Comput. Sci. 2002, 2265, 477-478
83. Hill, T.; Lewicki, P. STATISTICS Methods and Applications. A Comprehensive Reference for Science, Industry and Data Mining; StatSoft: Tulsa, 2006; Vol. 1, p 813.
84. Frank, E.; Hall, M.; Trigg, L.; Holmes, G.; Witten, I. H. Data mining in bioinformatics using Weka Bioinformatics 2004, 20, 2479-2481
85. Bisson, W. H. Editorial: Computational chemogenomics in drug design and discovery Curr. Top. Med. Chem. 2012, 12, 1867-1868
86. Cordeiro, M. N.; Speck-Planche, A. Editorial: Computer-aided drug design, synthesis and evaluation of new anti-cancer drugs Curr. Top. Med. Chem. 2012, 12, 2703-2704
87. Prado-Prado, F.; Garcia-Mera, X. Editorial: QSAR models for computer-aided drug design and molecular docking for disorders of the central nervous system and other diseases Curr. Top. Med. Chem. 2012, 12, 1731-1733
88. Gonzalez-Diaz, H. Quantitative studies on Structure-Activity and Structure-Property Relationships (QSAR/QSPR); 2008; Vol. 8, p 1554.
89. Gonzalez-Diaz, H. Editorial: QSAR/QSPR models as enabling technologies for drug & targets discovery in: medicinal chemistry, microbiology- parasitology, neurosciences, bioinformatics, proteomics and other biomedical sciences Curr. Top. Med. Chem. 2012, 12, 799-801
90. Alderson, R. G.; De Ferrari, L.; Mavridis, L.; McDonagh, J. L.; Mitchell, J. B.; Nath, N. Enzyme informatics Curr. Top. Med. Chem. 2012, 12, 1911-1923
91. Bisson, W. H. Drug repurposing in chemical genomics: can we learn from the past to improve the future? Curr. Top. Med. Chem. 2012, 12, 1883-1888
92. Castillo-Garit, J. A.; Abad, C.; Rodriguez-Borges, J. E.; Marrero-Ponce, Y.; Torrens, F. A review of QSAR studies to discover new drug-like compounds actives against leishmaniasis and trypanosomiasis Curr. Top. Med. Chem. 2012, 12, 852-865
93. Cedeno, W.; Alex, S.; Jaeger, E. P.; Agrafiotis, D. K.; Lobanov, V. S. An integrated data management framework for drug discovery - from data capturing to decision support Curr. Top. Med. Chem. 2012, 12, 1237-1242
94. Chatterjee, A. K.; Yeung, B. K. Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials Curr. Top. Med. Chem. 2012, 12, 473-483
95. Chen, J.; Wang, Y.; Guo, D.; Shen, B. A systems biology perspective on rational design of peptide vaccine against virus infections Curr. Top. Med. Chem. 2012, 12, 1310-1319
96. Cordero, F.; Beccuti, M.; Donatelli, S.; Calogero, R. A. Large disclosing the nature of computational tools for the analysis of next generation sequencing data Curr. Top. Med. Chem. 2012, 12, 1320-1330
97. Dave, K.; Lahiry, A. Conotoxins: review and docking studies to determine potentials of conotoxin as an anticancer drug molecule Curr. Top. Med. Chem. 2012, 12, 845-851
98. Dave, K.; Panchal, H. Review on chemogenomics approach: interpreting antagonist activity of secreted frizzled-related protein 1 in glaucoma disease with in-silico docking Curr. Top. Med. Chem. 2012, 12, 1834-1842
99. Faivre, C.; Barbolosi, D.; Iliadis, A. A new model for determining the MTD during phase-I trials in pediatric oncology Curr. Top. Med. Chem. 2012, 12, 1660-1664
100. Garcia, I.; Fall, Y.; Gomez, G. Review of synthesis, biological assay, and QSAR studies of HMGR inhibitors Curr. Top. Med. Chem. 2012, 12, 895-919
101. Jayadeepa, R. M.; Niveditha, M. S. Computational approaches to screen candidate ligands with anti- Parkinson's activity using R programming Curr. Top. Med. Chem. 2012, 12, 1807-1814
102. Khan, M. T.; Mischiati, C.; Ather, A.; Ohyama, T.; Dedachi, K.; Borgatti, M.; Kurita, N.; Gambari, R. Structure-based analysis of the molecular recognitions between HIV-1 TAR-RNA and transcription factor nuclear factor-kappaB (NFkB) Curr. Top. Med. Chem. 2012, 12, 814-827
103. Kobe, B.; Boden, M. Computational modelling of linear motif-mediated protein interactions Curr. Top. Med. Chem. 2012, 12, 1553-1561
104. Kramer, C.; Lewis, R. QSARs, data and error in the modern age of drug discovery Curr. Top. Med. Chem. 2012, 12, 1896-1902
105. Kufareva, I.; Chen, Y. C.; Ilatovskiy, A. V.; Abagyan, R. Compound activity prediction using models of binding pockets or ligand properties in 3D Curr. Top. Med. Chem. 2012, 12, 1869-1882
106. Lin, J. H. Target prediction of small molecules with information of key molecular interactions Curr. Top. Med. Chem. 2012, 12, 1903-1910
107. Luan, F.; Borges, F.; Cordeiro, M. N. Recent advances on A(3) adenosine receptor antagonists by QSAR tools Curr. Top. Med. Chem. 2012, 12, 878-894
108. Mortier, J.; Rakers, C.; Frederick, R.; Wolber, G. Computational tools for in silico fragment-based drug design Curr. Top. Med. Chem. 2012, 12, 1935-1943
109. Ortore, G.; Tuccinardi, T.; Martinelli, A. Computational studies on translocator protein (TSPO) and its ligands Curr. Top. Med. Chem. 2012, 12, 352-359
110. Popelier, P. New insights in atom-atom interactions for future drug design Curr. Top. Med. Chem. 2012, 12, 1924-1934
111. Prado-Prado, F.; Garcia-Mera, X.; Escobar, M.; Alonso, N.; Caamano, O.; Yanez, M.; Gonzalez-Diaz, H. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE Curr. Top. Med. Chem. 2012, 12, 1843-1865
112. Riera-Fernandez, I.; Martin-Romalde, R.; Prado-Prado, F. J.; Escobar, M.; Munteanu, C. R.; Concu, R.; Duardo-Sanchez, A.; Gonzalez-Diaz, H. From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments Indices Curr. Top. Med. Chem. 2012, 12, 927-960
113. Saladino, G.; Gervasio, F. L. New insights in protein kinase conformational dynamics Curr. Top. Med. Chem. 2012, 12, 1889-1895
114. Sharma, N.; Ethiraj, K. R.; Yadav, M.; Nayarisseri, S. A.; Chaurasiya, M.; Vankudavath, R. N.; Rao, K. R. Identification of LOGP values and electronegativities as structural insights to model inhibitory activity of HIV-1 capsid inhibitors-A SVM and MLR aided QSAR studies Curr. Top. Med. Chem. 2012, 12, 1763-1774
115. Speck-Planche, A.; Kleandrova, V. V. QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: computer-aided generation of new rasagiline bioisosteres Curr. Top. Med. Chem. 2012, 12, 1734-1747
116. Van Calenbergh, S.; Pochet, S.; Munier-Lehmann, H. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase Curr. Top. Med. Chem. 2012, 12, 694-705
117. Zhang, T.; Zhao, M.; Pang, Y.; Zhang, W.; Angela Liu, L.; Wei, D. Q. Recent progress on bioinformatics, functional genomics, and metabolomics research of cytochrome P450 and its impact on drug discovery Curr. Top. Med. Chem. 2012, 12, 1346-1355
118. Gonzalez-Diaz, H.; Romaris, F.; Duardo-Sanchez, A.; Perez-Montoto, L. G.; Prado-Prado, F.; Patlewicz, G.; Ubeira, F. M. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues Curr. Pharm. Des. 2010, 16, 2737-2764
119. Caballero, J.; Fernandez, M. Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1) Curr. Top. Med. Chem. 2008, 8, 1580-1605
120. Duardo-Sanchez, A.; Patlewicz, G.; Lopez-Diaz, A. Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues Curr. Top. Med. Chem. 2008, 8, 1666-1675
121. Ivanciuc, O. Weka machine learning for predicting the phospholipidosis inducing potential Curr. Top. Med. Chem. 2008, 8, 1691-1709
122. Wang, J. F.; Wei, D. Q.; Chou, K. C. Drug candidates from traditional chinese medicines Curr. Top. Med. Chem. 2008, 8, 1656-1665
123. Gonzalez-Diaz, H.; Vilar, S.; Santana, L.; Uriarte, E. Medicinal chemistry and bioinformatics-Current trends in drugs discovery with networks topological indices Curr. Top. Med. Chem. 2007, 7, 1015-1029
124. Bhattacharjee, B.; Jayadeepa, R. M.; Banerjee, S.; Joshi, J.; Middha, S. K.; Mole, J. P.; Samuel, J. Review of complex network and gene ontology in pharmacology approaches: Mapping natural compounds on potential drug target colon cancer network Curr. Bioinf. 2011, 6, 44-52
125. Dave, K.; Banerjee, A. Bioinformatics analysis of functional relations between CNPs regions Curr. Bioinf. 2011, 6, 122-128
126. García, I.; Fall, Y.; Gómez, G. Trends in bioinformatics and chemoinformatics of vitamin D analogues and their protein targets Curr. Bioinf. 2011, 6, 16-24
127. Ivanciuc, T.; Ivanciuc, O.; Klein, D. J. Network-QSAR with reaction poset quantitative superstructure-activity relationships (QSSAR) for PCB chromatographic properties Curr. Bioinf. 2011, 6, 25-34
128. Prado-Prado, F.; Escobar-Cubiella, M.; García-Mera, X. Review of bioinformatics and QSAR studies of β-secretase inhibitors Curr. Bioinf. 2011, 6, 3-15
129. Wan, S. B.; Hu, L. L.; Niu, S.; Wang, K.; Cai, Y. D.; Lu, W. C.; Chou, K. C. Identification of multiple subcellular locations for proteins in budding yeast Curr. Bioinf. 2011, 6, 71-80
130. Gonzalez-Diaz, H.; Duardo-Sanchez, A.; Ubeira, F. M.; Prado-Prado, F.; Perez-Montoto, L. G.; Concu, R.; Podda, G.; Shen, B. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers Curr. Drug Metab. 2010, 11, 379-406
131. Gonzalez-Diaz, H.; Arrasate, S.; Sotomayor, N.; Lete, E.; Munteanu, C. R.; Pazos, A.; Besada-Porto, L.; Ruso, J. M. MIANN models in medicinal, physical and organic chemistry Curr. Top. Med. Chem. 2013, 13, 619-641
132. Jeong, H.; Tombor, B.; Albert, R.; Oltvai, Z. N.; Barabasi, A. L. The large-scale organization of metabolic networks Nature 2000, 407, 651-654
133. Riera-Fernandez, P.; Munteanu, C. R.; Pedreira-Souto, N.; Martin-Romalde, R.; Duardo-Sanchez, A.; Gonzalez-Diaz, H. Definition of Markov-Harary invariants and review of classic topological indices and databases in biology, parasitology, technology, and social-legal networks Curr. Bioinf. 2011, 6, 94-121
134. Riera-Fernandez, P.; Munteanu, C. R.; Escobar, M.; Prado-Prado, F.; Martin-Romalde, R.; Pereira, D.; Villalba, K.; Duardo-Sanchez, A.; Gonzalez-Diaz, H. New Markov-Shannon entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, parasite-host, neural, industry, and legal-social networks J. Theor. Biol. 2012, 293, 174-188
135. Hopfield, J. J. Neural networks and physical systems with emergent collective computational abilities Proc. Natl. Acad. Sci. U. S. A. 1982, 79, 2554-2558
136. Box, G. E. P.; Jenkins, G. M. Time series analysis; Holden-Day: San Francisco, 1970; p 553.
137. Hill, T.; Lewicki, P. STATISTICS Methods and Applications; StatSoft: Tulsa, 2006.
138. Mazurie, A.; Bonchev, D.; Schwikowski, B.; Buck, G. A. Evolution of metabolic network organization BMC Syst. Biol. 2010, 4, 59
139. Kier, L. B.; Bonchev, D.; Buck, G. A. Modeling biochemical networks: a cellular-automata approach Chem. Biodivers. 2005, 2, 233-243
140. Rosa da Silva, M.; Sun, J.; Ma, H. W.; He, F.; Zeng, A. P. Metabolic networks. In Analysis of biological networks; Junker, B. H.; Schreiber, F., Eds.; Wiley & Sons: NJ, 2008, pp 233-253.
141. Lee, D. S.; Park, J.; Kay, K. A.; Christakis, N. A.; Oltvai, Z. N.; Barabasi, A. L. The implications of human metabolic network topology for disease comorbidity Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 9880-9885
142. Rosenblatt, F. Principles of neurodynamics; perceptrons and the theory of brain mechanisms; Spartan Books: WA, 1962.
143. Wasserman, S.; Faust, K. Social network analysis: methods and applications; Cambridge University Press: Cambridge, 1999.
144. Fowler, J. H.; Jeon, S. The authority of Supreme Court precedent Social Networks 2008, 30, 16-30
145. Duardo-Sánchez, A. Study of criminal law networks with Markov-probability centralities. In Topological Indices for Medicinal Chemistry, Biology, Parasitology, Neurological and Social Networks; González- Díaz, H., Ed.; Bentham: Kerala, India, 2010; Chapter 12, pp 205-212.
146. Duardo-Sánchez, A. Criminal law networks, markov chains, Shannon entropy and artificial neural networks. In Complex Network Entropy: From Molecules to Biology, Parasitology, Technology, Social, Legal, and Neurosciences; González-Díaz, H., Ed.; Bentham: Kerala, India, 2011; Chapter 8, pp 107-114.